Clinuvel Pharmaceuticals Ltd
ASX:CUV
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Price:
9.61
AUD
-0.31%
Market Closed
Market Cap:
AU$482.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
AU |
|
H
|
Hoang Anh Gia Lai Agricultural JSC
VN:HNG
|
VN |
|
G
|
Guangdong Delian Group Co Ltd
SZSE:002666
|
CN |
|
Evonik Industries AG
XETRA:EVK
|
DE |
|
Wilhelmina International Inc
NASDAQ:WHLM
|
US |
|
Fortis Inc
TSX:FTS
|
CA |
|
Hauppauge Digital Inc
OTC:HAUP
|
US |
|
L
|
Lfe Corporation Bhd
KLSE:LFECORP
|
MY |
|
Sagar Diamonds Ltd
BSE:540715
|
IN |
|
Gold Terra Resource Corp
XTSX:YGT
|
CA |
|
B
|
Brite-Tech Bhd
KLSE:BTECH
|
MY |
Relative Value
The Relative Value of one
CUV
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 9.61 AUD,
Clinuvel Pharmaceuticals Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CUV Relative Value
HIDDEN
Multiples Across Competitors
CUV Competitors Multiples
Clinuvel Pharmaceuticals Ltd Competitors
Clinuvel Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
483.9m AUD | 5 | 14.8 | 5.8 | 5.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
